Detalle Publicación

Association between benzodiazepine use and development of dementia
Autores: Aldaz, P. (Autor de correspondencia); Garjon, J.; Beitia Berrotaran, Guadalupe; Beltrán Garate, Idoya; Librero, J.; Ibanez, B.; Arroyo, P.; Ariz, M. J.
Título de la revista: MEDICINA CLINICA
ISSN: 0025-7753
Volumen: 156
Número: 3
Páginas: 107 - 111
Fecha de publicación: 2021
Lugar: WOS
Objective: To evaluate the association between use of benzodiazepines and incident dementia. Methods: Analytical prospective nested case-control study for which the Spanish database for pharmacoepidemiological research in primary care (BIFAP) of the Spanish Agency of Medicines and Medical Devices (AEMPS) was used. A total of 15,212 subjects diagnosed with dementia of the Alzheimer type and 62,397 controls were identified. Exposure was retrieved retrospectively with a 3-year lag time before the index date. Adjusted odd ratios (OR) were calculated. Results: Benzodiazepines use increased the risk of suffering Alzheimer's disease (OR = 1.05, 95% CI, 1.01-1.10). No statistical differences were shown between short-acting and long-acting drugs. The risk is more evident with longer exposure times. Conclusions: There seems to be a weak association between benzodiazepine use and the development of dementia, the risk increases with greater exposure. (C) 2020 Elsevier Espana, S.L.U. All rights reserved.